Call Us: 1.800.873.5297


What Is an FDA “Black Box” Warning?

blackBoxWarningsIf you take prescription drugs, the chances are that you have seen a “black box” warning on the prescribing information. These warnings, officially known as boxed warnings and generally placed because the FDA orders them, are used to highlight the most serious potential risks and side effects associated with a prescription drug. These warnings are placed at the top of the prescribing information and are intended to limit potential serious injury from the use of a particular prescription drug. Ablack box warning is not the same as an FDA recall of drugs.

The black box warnings highlight the most serious risks associated with particular prescription drugs. If you suffered one of these dangerous side effects, you may wonder what your legal options are. To discuss your injury with an experienced drug recall lawyer, please call or email Schlichter, Bogard & Denton today.

Black Box vs. Boxed Warning

Although the two terms are used interchangeably by the FDA and by media in describing the warning, “boxed warning” is the official name of the warnings. Some doctors, scientists, and other professionals in the drug industry have objected to the use of the term “black box” because of its morbid associations.

Why the Black Box?

The boxed warnings were created in 1979 by the FDA to highlight “special problems, particularly those that may lead to death or serious injury.” Initially, the placement of the boxed warning was discretionary, but recently the rules have been amended to say that the boxed warning should always follow immediately after the drug’s basic information, including its names (trade and chemical), its dosage form and route of administration, and its initial date of US approval.

When a Black Box Is Used

According the FDA’s revised guidelines for drug manufacturers, a boxed warning should be used to highlight information that is especially important to prescribers:

  • There is a serious adverse reaction that might outweigh the potential benefit of a drug, like LevaquinReglan, or TNF blockers
  • There is a serious adverse reaction that can be prevented or reduced with appropriate patient selection, monitoring, avoiding or adding another drug, or other methods. Drugs with this type of black box warning include oral sodium phosphate, gadolinium-based contrast agents, Paxil and Prozac, or TNF blockers
  • FDA approval was conditional to certain limitations, such as being restricted for certain ages

Most often, the FDA will only put a boxed warning on a drug after certain adverse reactions have been observed. Sometimes, though, a warning might be put on a drug because certain adverse reactions have been associated with other similar drugs.

Black Box Warning vs. FDA Recall

Some people may be confused about the difference between a black box warning and an FDA recall of a dangerous or defective drug. A black box warning is primarily directed at doctors and other health care providers. It provides information that doctors should take into account when prescribing drugs to people. It is not intended to tell people that they should immediately stop taking a drug. Instead, if you learn that a drug you are taking has been given a new black box warning, you should talk to your doctor.

An FDA recall of a drug on the other hand, is directed not only at doctors, pharmacists, and other health care professionals, but at you as a person taking the drug. It often includes specific instructions about how to stop taking the drug, how to return or destroy unused product, and how to talk to your doctor about future alternative treatments.

If you would like to learn more about FDA recalls and what legal options you may have after your drug-related injury, please contact the drug recall lawyers at Schlichter, Bogard & Denton today.

000-017   000-080   000-089   000-104   000-105   000-106   070-461   100-101   100-105  , 100-105  , 101   101-400   102-400   1V0-601   1Y0-201   1Z0-051   1Z0-060   1Z0-061   1Z0-144   1z0-434   1Z0-803   1Z0-804   1z0-808   200-101   200-120   200-125  , 200-125  , 200-310   200-355   210-060   210-065   210-260   220-801   220-802   220-901   220-902   2V0-620   2V0-621   2V0-621D   300-070   300-075   300-101   300-115   300-135   3002   300-206   300-208   300-209   300-320   350-001   350-018   350-029   350-030   350-050   350-060   350-080   352-001   400-051   400-101   400-201   500-260   640-692   640-911   640-916   642-732   642-999   700-501   70-177   70-178   70-243   70-246   70-270   70-346   70-347   70-410   70-411   70-412   70-413   70-417   70-461   70-462   70-463   70-480   70-483   70-486   70-487   70-488   70-532   70-533   70-534   70-980   74-678   810-403   9A0-385   9L0-012   9L0-066   ADM-201   AWS-SYSOPS   C_TFIN52_66   c2010-652   c2010-657   CAP   CAS-002   CCA-500   CISM   CISSP   CRISC   EX200   EX300   HP0-S42   ICBB   ICGB   ITILFND   JK0-022   JN0-102   JN0-360   LX0-103   LX0-104   M70-101   MB2-704   MB2-707   MB5-705   MB6-703   N10-006   NS0-157   NSE4   OG0-091   OG0-093   PEGACPBA71V1   PMP   PR000041   SSCP   SY0-401   VCP550  

Legal Disclaimer & Privacy Policy
This web site is designed for general information only. The information presented should not be construed as legal advice and does not form the basis for an attorney/client relationship.

The choice of a lawyer is an important decision and should not be based solely on advertisements.
This web site is not intended to be advertising, and Schlichter Bogard & Denton LLP does not desire to represent anyone desiring representation based upon viewing this web site in a jurisdiction where this web site fails to comply with all laws and ethical rules of that jurisdiction. Materials on this web site may only be reproduced in their entirety (without modification) for the individual reader's personal and/or educational use and must include this notice.

We will not disclose, sell, or rent any of your identifiable personal information to any third party, unless approved by you, or required by law.